April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
Pasithea Therapeutics (KTTA) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: May 15, 2025 (20:55)
Sector: HealthcareThe share price of Pasithea Therapeutics Corp. (KTTA) now
Are you interested in Pasithea Therapeutics Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Pasithea Therapeutics stock price in 2025, 2026, 2027. How much will one Pasithea Therapeutics share be worth in 2025 - 2027?
When should I take profit in Pasithea Therapeutics stock? When should I record a loss on Pasithea Therapeutics stock? What are analysts' forecasts for Pasithea Therapeutics stock? What is the future of Pasithea Therapeutics stock? We forecast Pasithea Therapeutics stock performance using neural networks based on historical data on Pasithea Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Pasithea Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Pasithea Therapeutics shares. This happens once a day.
Historical and forecast chart of Pasithea Therapeutics stock
The chart below shows the historical price of Pasithea Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Pasithea Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Pasithea specializes in the discovery and development of new drugs for the treatment of psychiatric and neurological disorders. The company does not currently have a leading candidate drug in development. In the 24 months following its IPO, the company plans to discover three leading candidate compounds targeting the immune system’s link to certain mental disorders. An additional Pasithea business is to open depression clinics in the UK and the US, where doctors will administer ketamine intravenously to patients when indicated.
Pasithea Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 17 | 0.98 | 0.96 | 1.01 | 5.36 |
| May 18 | 0.97 | 0.94 | 0.99 | 5.00 |
| May 19 | 0.94 | 0.91 | 0.95 | 4.53 |
| May 20 | 0.92 | 0.89 | 0.94 | 5.22 |
| May 21 | 0.95 | 0.93 | 0.96 | 2.43 |
| May 22 | 0.94 | 0.91 | 0.95 | 4.29 |
| May 23 | 0.94 | 0.92 | 0.96 | 4.19 |
| May 24 | 0.93 | 0.90 | 0.96 | 5.80 |
| May 25 | 0.93 | 0.91 | 0.94 | 3.64 |
| May 26 | 0.93 | 0.92 | 0.94 | 2.64 |
| May 27 | 0.94 | 0.91 | 0.95 | 4.09 |
| May 28 | 0.93 | 0.90 | 0.96 | 6.48 |
| May 29 | 0.93 | 0.91 | 0.94 | 3.96 |
| May 30 | 0.93 | 0.91 | 0.96 | 4.73 |
| May 31 | 0.96 | 0.93 | 0.98 | 5.80 |
| Jun 01 | 0.96 | 0.95 | 0.98 | 3.00 |
| Jun 02 | 0.94 | 0.92 | 0.98 | 6.26 |
| Jun 03 | 0.95 | 0.94 | 0.97 | 3.74 |
| Jun 04 | 0.95 | 0.92 | 0.97 | 4.77 |
| Jun 05 | 0.94 | 0.92 | 0.96 | 4.47 |
| Jun 06 | 0.95 | 0.93 | 0.96 | 3.23 |
| Jun 07 | 0.93 | 0.91 | 0.95 | 5.19 |
| Jun 08 | 0.97 | 0.94 | 0.98 | 4.52 |
| Jun 09 | 0.99 | 0.98 | 1.00 | 2.51 |
| Jun 10 | 1.02 | 0.99 | 1.04 | 4.60 |
| Jun 11 | 1.06 | 1.04 | 1.07 | 3.17 |
| Jun 12 | 1.07 | 1.03 | 1.10 | 6.19 |
| Jun 13 | 1.04 | 1.03 | 1.06 | 3.16 |
| Jun 14 | 1.06 | 1.04 | 1.09 | 5.12 |
| Jun 15 | 1.03 | 1.00 | 1.05 | 4.07 |
Pasithea Therapeutics Daily Price Targets
Pasithea Therapeutics Stock Forecast 05-17-2025.
Forecast target price for 05-17-2025: $0.98.
Positive dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 5.087%.
Pessimistic target level: 0.96
Optimistic target level: 1.01
Pasithea Therapeutics Stock Forecast 05-18-2025.
Forecast target price for 05-18-2025: $0.97.
Negative dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 4.758%.
Pessimistic target level: 0.94
Optimistic target level: 0.99
Pasithea Therapeutics Stock Forecast 05-19-2025.
Forecast target price for 05-19-2025: $0.94.
Negative dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 4.331%.
Pessimistic target level: 0.91
Optimistic target level: 0.95
Pasithea Therapeutics Stock Forecast 05-20-2025.
Forecast target price for 05-20-2025: $0.92.
Negative dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 4.965%.
Pessimistic target level: 0.89
Optimistic target level: 0.94
Pasithea Therapeutics Stock Forecast 05-21-2025.
Forecast target price for 05-21-2025: $0.95.
Positive dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 2.373%.
Pessimistic target level: 0.93
Optimistic target level: 0.96
Pasithea Therapeutics Stock Forecast 05-22-2025.
Forecast target price for 05-22-2025: $0.94.
Negative dynamics for Pasithea Therapeutics shares will prevail with possible volatility of 4.111%.
Pessimistic target level: 0.91
Optimistic target level: 0.95
KTTA (KTTA) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 5.05 | -19.20 | 30.34 | 163.28 |
| Jul. | 23.06 | -97.17 | 56.29 | 272.65 |
| Aug. | 100.58 | -189.22 | 314.48 | 160.17 |
| Sep. | -368.62 | -2 062.85 | 895.74 | 330.30 |
| Oct. | 86.55 | -192.51 | 531.86 | 136.20 |
| Nov. | 104.36 | -396.79 | 247.55 | 260.29 |
| Dec. | 197.43 | -533.94 | 1 145.51 | 146.61 |
Pasithea Therapeutics forecast for this year
Pasithea Therapeutics Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $5.04949. Pessimistic: $-19.20. Optimistic: $30.34
Pasithea Therapeutics Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $23.062. Pessimistic: $-97.17. Optimistic: $56.29
Pasithea Therapeutics Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $100.583. Pessimistic: $-189.22. Optimistic: $314.48
Pasithea Therapeutics Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $-368.616. Pessimistic: $-2 062.85. Optimistic: $895.74
Pasithea Therapeutics Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $86.5509. Pessimistic: $-192.51. Optimistic: $531.86
Pasithea Therapeutics Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $104.363. Pessimistic: $-396.79. Optimistic: $247.55
Pasithea Therapeutics Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $197.434. Pessimistic: $-533.94. Optimistic: $1 145.51
Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 698.56 | -739.08 | 3 573.84 | 120.68 |
| Feb | 2 711.26 | -1 752.56 | 14 986.70 | 111.69 |
| Mar | 14 056.80 | -25 479.30 | 69 021.60 | 136.91 |
| Apr | 3 449.53 | -8 145.73 | 17 411.20 | 146.78 |
| May | -20 214.30 | -68 748.70 | 38 027.10 | 280.79 |
| Jun | -81 229.00 | -265 115.00 | 158 380.00 | 267.39 |
| Jul | -554 875.00 | -2 267 780.00 | 2 376 090.00 | 195.44 |
| Aug | -1 049 710.00 | -3 138 010.00 | 4 135 030.00 | 175.89 |
| Sep | 1 110 600.00 | -2 698 750.00 | 4 615 200.00 | 158.48 |
| Oct | 1 339 160.00 | -1 508 690.00 | 5 565 000.00 | 127.11 |
| Nov | 2 165 950.00 | -9 126 460.00 | 5 880 560.00 | 255.20 |
| Dec | 1 274 450.00 | -2 572 340.00 | 7 569 200.00 | 133.98 |
Pasithea Therapeutics (KTTA) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | -5 195 160.00 | -20 519 800.00 | 7 278 410.00 | 381.93 |
| Feb | 29 374 400.00 | -113 697 000.00 | 158 340 000.00 | 171.81 |
| Mar | 7 208 490.00 | -16 527 600.00 | 18 582 000.00 | 188.94 |
| Apr | -22 461 700.00 | -139 568 000.00 | 66 908 800.00 | 308.59 |
| May | -176 549 000.00 | -1 024 330 000.00 | 102 010 000.00 | 1,104.15 |
| Jun | -1 000 110 000.00 | -5 116 580 000.00 | 3 184 960 000.00 | 260.65 |
| Jul | -6 214 300 000.00 | -19 855 900 000.00 | 10 837 700 000.00 | 283.21 |
| Aug | -31 366 100 000.00 | -188 441 000 000.00 | 13 819 900 000.00 | 1,463.55 |
| Sep | 127 861 000 000.00 | -135 276 000 000.00 | 820 788 000 000.00 | 116.48 |
| Oct | 136 632 000 000.00 | -547 593 000 000.00 | 408 447 000 000.00 | 234.07 |
| Nov | -425 745 000 000.00 | -2 470 170 000 000.00 | 1 735 510 000 000.00 | 242.33 |
| Dec | 2 436 450 000 000.00 | -9 430 530 000 000.00 | 15 139 100 000 000.00 | 162.29 |
Pasithea Therapeutics information and performance
2110 NARCISSUS CT, VENICE, CA, US
Market capitalization of the Pasithea Therapeutics Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of KTTA shares in the company outstanding by the market price of one share.
EBITDA of Pasithea Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Pasithea Therapeutics Stock)
Should I Buy Pasithea Therapeutics Shares in 2025 year?
Does Pasithea Therapeutics pay dividends?
Which economic sector do Pasithea Therapeutics's shares belong to?
Which other securities belong to the same sector as Pasithea Therapeutics's shares?
